Torrent Pharmaceuticals Limited

NSE: TORNTPHARM · Healthcare · Lot size: 250

OverviewOption ChainOI AnalysisFII / DIIMax Pain

Torrent Pharmaceuticals Limited Share Price & Analysis

₹4,416Updated 5 Jun 2026, 03:30 pm IST
LTP
₹4,416
—
Open
₹4,350
High
₹4,453.5
Low
₹4,323
Close
₹4,339.9
52W High
₹4,714
52W Low
₹3,109
Volume
425K
Lot Size
250
Sector
Healthcare
Market Cap
₹1.5L Cr
Face Value
₹5
Large CapNIFTY 100NIFTY 200NIFTY 500NEXT 50

Price Chart

Fundamentals

P/E
66.4
Sector P/E
48.9
P/B
17.81
EPS
₹67.12
ROE
27.6%
ROCE
15.4%
D/E Ratio
1.79
Div Yield
0.88%
Book Value
₹248
+

Strengths

  • ✓Excellent return on equity (ROE 27.6%)
  • ✓Efficient capital deployment (ROCE 15.4%)
−

Concerns

  • ✗High premium to book value (P/B 17.8x)
  • ✗Elevated debt levels (D/E 1.8x)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
₹1,783
₹4.3L Cr34.45.121620.50.07
DIVISLAB
Divi's Laboratories Limited
₹6,616
₹1.7L Cr66.110.4816.5220.01
APOLLOHOSP
Apollo Hospitals Enterprise Limited
₹8,315
₹1.2L Cr59.512.6222.117.90.88
CIPLA
Cipla Limited
₹1,402
₹1.1L Cr27.33.2912.416.60.01
ZYDUSLIFE
Zydus Lifesciences Limited
₹1,091
₹1.1L Cr204.0521.221.20.38
DRREDDY
Dr. Reddy's Laboratories Limited
₹1,283
₹1.1L Cr25.42.8311.813.60.16
LUPIN
Lupin Limited
₹2,260
₹1.0L Cr17.94.629.130.30.32

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

TORNTPHARM · as of Mar 2026

Promoters68.31%
FII16.31%▲0.14
DII8.25%
Public7.02%▼0.15
Govt0.10%
CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters71.25%71.25%71.25%71.25%68.31%68.31%
FII14.08%14.14%14.22%14.46%16.17%16.31%
DII7.11%7.15%7.17%6.98%8.25%8.25%
Public7.46%7.34%7.25%7.21%7.17%7.02%
Govt0.10%0.10%0.10%0.10%0.10%0.10%

Corporate Events

Dividend - Rs 9 Per Share

Dividend28 May 2026

To consider and approve the financial results for the period ended March 31, 2026, dividend, Fund Raising and other business matters

Dividend21 May 2026

Interim Dividend - Rs 29 Per Share

Record: 18 Feb 2026

Dividend17 Feb 2026

Dividend - Rs 6 Per Share

Dividend19 Jun 2025

Interim Dividend - Rs 26 Per Sh

Record: 31 Jan 2025

Dividend30 Jan 2025

Dividend - Rs 6 Per Share

Dividend20 Jun 2024

Interim Dividend - Rs 22 Per Share

Dividend11 Feb 2024

Dividend - Rs 8 Per Share

Dividend22 Jun 2023

Latest News

All news →

Torrent Pharma gets FDA approval for new drug

*Torrent Pharma gets FDA approval for new drug* — The company received FDA nod for its **Valsartan** tablets, boosting its U.S. generics portfolio. This approval enhances export potential and may contribute to revenue growth. Market reaction expected positive on volume support. 📊 *STOCKS:* TORNTPHARM | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #FDA

AD HOC NEWS19 May
Medium Impact

Torrent Pharma, JB Chemicals merger nears completion

*Torrent Pharma, JB Chemicals merger nears completion.* Talks are advancing despite **valuation disagreements** between the two pharma firms. The deal could reshape market positioning in India’s domestic pharmaceutical space. A final decision is expected within weeks. 📊 *STOCKS:* TORNTPHARM, JBMA | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #Merger

Whalesbook12 May
High Impact

Financials

Quarterly Results

MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
Revenue
₹3.3K Cr
▲0.0%
₹3.3K Cr
▲3.9%
₹3.2K Cr
▲7.4%
₹3.0K Cr
▲5.3%
₹2.8K Cr
▼2.8%
₹2.9K Cr
▲1.0%
₹2.9K Cr
▲4.2%
₹2.7K Cr
Op. Profit
₹1.1K Cr
▲0.5%
₹1.1K Cr
▲4.9%
₹1.0K Cr
▲7.1%
₹964 Cr
▲5.5%
₹914 Cr
▼2.7%
₹939 Cr
▲3.9%
₹904 Cr
▲2.4%
₹883 Cr
OPM
33.0%
▲0.0%
33.0%
▲3.1%
32.0%
▼3.0%
33.0%
▲0.0%
33.0%
▲3.1%
32.0%
▲0.0%
32.0%
▲0.0%
32.0%
Net Profit
₹635 Cr
▲7.4%
₹591 Cr
▲7.8%
₹548 Cr
▲10.0%
₹498 Cr
▼1.0%
₹503 Cr
▲11.0%
₹453 Cr
▼0.9%
₹457 Cr
▲1.8%
₹449 Cr
EPS (₹)
18.76
▲7.4%
17.46
▲7.8%
16.19
▲10.1%
14.71
▼1.0%
14.86
▲11.1%
13.38
▼0.9%
13.5
▲1.7%
13.27

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Revenue
₹14.0K Cr
▲21.4%
₹11.5K Cr
▲7.3%
₹10.7K Cr
▲11.5%
₹9.6K Cr
▲13.1%
₹8.5K Cr
▲6.3%
₹8.0K Cr
▲0.8%
₹7.9K Cr
▲3.5%
₹7.7K Cr
▲29.0%
₹6.0K Cr
▲2.3%
₹5.8K Cr
Expenses
₹9.4K Cr
▲20.9%
₹7.8K Cr
▲5.9%
₹7.4K Cr
▲8.6%
₹6.8K Cr
▲11.5%
₹6.1K Cr
▲10.0%
₹5.5K Cr
▼4.2%
₹5.8K Cr
▲1.4%
₹5.7K Cr
▲23.7%
₹4.6K Cr
▲3.7%
₹4.4K Cr
Op. Profit
₹4.6K Cr
▲22.5%
₹3.7K Cr
▲10.5%
₹3.4K Cr
▲18.5%
₹2.8K Cr
▲16.9%
₹2.4K Cr
▼2.0%
₹2.5K Cr
▲14.3%
₹2.2K Cr
▲9.4%
₹2.0K Cr
▲47.0%
₹1.3K Cr
▼2.0%
₹1.4K Cr
OPM
33.0%
▲3.1%
32.0%
▲3.2%
31.0%
▲3.3%
30.0%
▲3.4%
29.0%
▼6.5%
31.0%
▲14.8%
27.0%
▲3.8%
26.0%
▲13.0%
23.0%
▼4.2%
24.0%
Other Income
₹-183 Cr
▼18200.0%
₹-1 Cr
▼100.7%
₹146 Cr
▲224.4%
₹45 Cr
▲115.6%
₹-288 Cr
▼605.3%
₹57 Cr
▼52.9%
₹121 Cr
▲140.3%
₹-300 Cr
▼200.3%
₹299 Cr
▲34.1%
₹223 Cr
Interest
₹385 Cr
▲52.8%
₹252 Cr
▼28.8%
₹354 Cr
▲6.3%
₹333 Cr
▲30.6%
₹255 Cr
▼27.8%
₹353 Cr
▼21.7%
₹451 Cr
▼10.5%
₹504 Cr
▲63.6%
₹308 Cr
▲49.5%
₹206 Cr
Depreciation
₹1.1K Cr
▲40.8%
₹795 Cr
▼1.6%
₹808 Cr
▲14.3%
₹707 Cr
▲6.8%
₹662 Cr
▲0.6%
₹658 Cr
▲0.6%
₹654 Cr
▲5.8%
₹618 Cr
▲51.1%
₹409 Cr
▲33.2%
₹307 Cr
PBT
₹2.9K Cr
▲7.4%
₹2.7K Cr
▲13.6%
₹2.4K Cr
▲27.3%
₹1.8K Cr
▲50.7%
₹1.2K Cr
▼19.7%
₹1.5K Cr
▲28.6%
₹1.2K Cr
▲111.2%
₹562 Cr
▼39.6%
₹931 Cr
▼14.4%
₹1.1K Cr
Tax %
26.0%
▼7.1%
28.0%
▼6.7%
30.0%
▼9.1%
33.0%
▼10.8%
37.0%
▲105.6%
18.0%
▲28.6%
14.0%
▼36.4%
22.0%
▼18.5%
27.0%
▲92.9%
14.0%
Net Profit
₹2.1K Cr
▲11.9%
₹1.9K Cr
▲15.4%
₹1.7K Cr
▲33.0%
₹1.2K Cr
▲60.2%
₹777 Cr
▼37.9%
₹1.3K Cr
▲22.1%
₹1.0K Cr
▲135.1%
₹436 Cr
▼35.7%
₹678 Cr
▼27.4%
₹934 Cr
EPS (₹)
63.17
▲11.9%
56.47
▲15.4%
48.94
▲33.0%
36.79
▲60.2%
22.97
▼37.9%
36.99
▲22.2%
30.28
▲134.9%
12.89
▼35.7%
20.04
▼27.4%
27.59
Div Payout
0.0%
▼100.0%
57.0%
▲0.0%
57.0%
▼5.0%
60.0%
▼42.9%
105.0%
▲123.4%
47.0%
▼11.3%
53.0%
▼19.7%
66.0%
▲88.6%
35.0%
▲40.0%
25.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemSep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Liabilities
Equity Capital
₹169 Cr
▲0.0%
₹169 Cr
▲0.0%
₹169 Cr
▲0.0%
₹169 Cr
▲98.8%
₹85 Cr
▲0.0%
₹85 Cr
▲0.0%
₹85 Cr
▲0.0%
₹85 Cr
▲0.0%
₹85 Cr
▲0.0%
₹85 Cr
Reserves
₹8.3K Cr
▲11.6%
₹7.4K Cr
▲11.0%
₹6.7K Cr
▲10.9%
₹6.0K Cr
▲2.7%
₹5.9K Cr
▲2.0%
₹5.8K Cr
▲21.4%
₹4.7K Cr
▲2.1%
₹4.6K Cr
▲2.2%
₹4.5K Cr
▲6.4%
₹4.3K Cr
Borrowings
₹2.8K Cr
▼11.9%
₹3.2K Cr
▼20.4%
₹4.0K Cr
▼25.1%
₹5.4K Cr
▲31.9%
₹4.1K Cr
▼16.5%
₹4.9K Cr
▼15.7%
₹5.8K Cr
▼4.2%
₹6.0K Cr
▼6.6%
₹6.5K Cr
▲157.5%
₹2.5K Cr
Other Liabilities
₹4.2K Cr
▲17.8%
₹3.6K Cr
▼0.7%
₹3.6K Cr
▲19.2%
₹3.0K Cr
▲5.5%
₹2.9K Cr
▼14.2%
₹3.4K Cr
▼1.1%
₹3.4K Cr
▲1.5%
₹3.4K Cr
▲6.1%
₹3.2K Cr
▲15.3%
₹2.7K Cr
Total Liabilities
₹15.5K Cr
▲7.8%
₹14.4K Cr
▼0.8%
₹14.5K Cr
▼0.7%
₹14.6K Cr
▲13.2%
₹12.9K Cr
▼8.3%
₹14.1K Cr
▲0.5%
₹14.0K Cr
▼0.7%
₹14.1K Cr
▼0.9%
₹14.2K Cr
▲48.3%
₹9.6K Cr
Assets
Fixed Assets
₹7.8K Cr
▼1.3%
₹7.9K Cr
▼2.3%
₹8.1K Cr
▲0.2%
₹8.1K Cr
▲26.4%
₹6.4K Cr
▼9.1%
₹7.1K Cr
▼6.2%
₹7.5K Cr
▼2.8%
₹7.7K Cr
▼1.4%
₹7.9K Cr
▲113.0%
₹3.7K Cr
CWIP
₹488 Cr
▲2.1%
₹478 Cr
▲32.4%
₹361 Cr
▼52.8%
₹765 Cr
▲21.4%
₹630 Cr
▼29.1%
₹889 Cr
▲24.9%
₹712 Cr
▲15.4%
₹617 Cr
▼4.6%
₹647 Cr
▲24.7%
₹519 Cr
Investments
₹133 Cr
▼14.7%
₹156 Cr
▼9.8%
₹173 Cr
▼13.1%
₹199 Cr
▼11.9%
₹226 Cr
▲24.9%
₹181 Cr
▲8950.0%
₹2 Cr
▼99.4%
₹353 Cr
▼28.3%
₹492 Cr
▼38.8%
₹804 Cr
Other Assets
₹7.1K Cr
▲21.3%
₹5.8K Cr
▼0.3%
₹5.8K Cr
▲5.6%
₹5.5K Cr
▼1.8%
₹5.6K Cr
▼5.3%
₹5.9K Cr
▲3.1%
₹5.8K Cr
▲6.8%
₹5.4K Cr
▲2.8%
₹5.2K Cr
▲14.4%
₹4.6K Cr
Total Assets
₹15.5K Cr
▲7.8%
₹14.4K Cr
▼0.8%
₹14.5K Cr
▼0.7%
₹14.6K Cr
▲13.2%
₹12.9K Cr
▼8.3%
₹14.1K Cr
▲0.5%
₹14.0K Cr
▼0.7%
₹14.1K Cr
▼0.9%
₹14.2K Cr
▲48.3%
₹9.6K Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Operating CF
₹2.6K Cr
▼20.9%
₹3.3K Cr
▲37.9%
₹2.4K Cr
▲31.3%
₹1.8K Cr
▼10.1%
₹2.0K Cr
▲43.9%
₹1.4K Cr
▼22.5%
₹1.8K Cr
▲101.1%
₹894 Cr
▼11.4%
₹1.0K Cr
▼63.2%
₹2.7K Cr
Investing CF
₹-549 Cr
▼243.1%
₹-160 Cr
▲93.1%
₹-2.3K Cr
▼1091.3%
₹-196 Cr
▲55.9%
₹-444 Cr
▼293.9%
₹229 Cr
▲193.1%
₹-246 Cr
▲94.7%
₹-4.7K Cr
▼486.1%
₹-798 Cr
▲8.2%
₹-869 Cr
Financing CF
₹-2.3K Cr
▲17.3%
₹-2.8K Cr
▼3710.4%
₹77 Cr
▲104.3%
₹-1.8K Cr
▼7.9%
₹-1.7K Cr
▼6.6%
₹-1.5K Cr
▼17.9%
₹-1.3K Cr
▼138.5%
₹3.4K Cr
▲1870.5%
₹-193 Cr
▲86.6%
₹-1.4K Cr
Net Cash Flow
₹-262 Cr
▼180.1%
₹327 Cr
▲197.3%
₹110 Cr
▲163.2%
₹-174 Cr
▼95.5%
₹-89 Cr
▼221.9%
₹73 Cr
▼69.3%
₹238 Cr
▲165.0%
₹-366 Cr
▼2133.3%
₹18 Cr
▼95.9%
₹437 Cr
Free Cash Flow
₹2.0K Cr
▼32.9%
₹3.0K Cr
▲51.9%
₹2.0K Cr
▲21.5%
₹1.6K Cr
▼3.8%
₹1.7K Cr
▲68.8%
₹990 Cr
▼13.0%
₹1.1K Cr
▲983.8%
₹105 Cr
▼79.9%
₹523 Cr
▼75.7%
₹2.1K Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Debtor Days
59d
▼6.3%
63d
▼14.9%
74d
▲5.7%
70d
▲1.4%
69d
▼9.2%
76d
▲11.8%
68d
▼11.7%
77d
▲28.3%
60d
▼24.1%
79d
Inventory Days
334d
▲7.7%
310d
▲4.0%
298d
▼19.0%
368d
▼19.3%
456d
▲26.0%
362d
▲13.8%
318d
▼25.9%
429d
▲34.9%
318d
▲1.3%
314d
Days Payable
239d
▼15.8%
284d
▲26.8%
224d
▼10.4%
250d
▼28.8%
351d
▲1.7%
345d
▲0.0%
345d
▼22.8%
447d
▲25.6%
356d
▼31.9%
523d
Cash Conv. Cycle
154d
▲73.0%
89d
▼39.5%
147d
▼21.8%
188d
▲8.0%
174d
▲87.1%
93d
▲121.4%
42d
▼28.8%
59d
▲181.0%
21d
▲116.2%
-130d
Working Capital Days
7d
▲125.9%
-27d
▲18.2%
-33d
▼571.4%
7d
▲240.0%
-5d
▲90.4%
-52d
▲16.1%
-62d
▲22.5%
-80d
▼385.7%
28d
▲2900.0%
-1d
ROCE
27.0%
▲17.4%
23.0%
▲15.0%
20.0%
▲5.3%
19.0%
▲11.8%
17.0%
▲13.3%
15.0%
▲15.4%
13.0%
▲0.0%
13.0%
▼31.6%
19.0%
▼60.4%
48.0%

Source: Screener.in · Lower days = better efficiency

Deep Dive Analysis

Option Chain
Strike-wise OI & IV
OI Analysis
PCR, buildup type
FII / DII
Institutional flows
Max Pain
Writer pain levels

About Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.[1]

Healthcare · Pharmaceuticals & Biotechnology

Related Analysis

Same Sector

ALKEM
Alkem Laboratories Limited
Neutral
APOLLOHOSP
Apollo Hospitals Enterprise Limited
Neutral
AUROPHARMA
Aurobindo Pharma Limited
Neutral
BIOCON
Biocon Limited
Neutral
CIPLA
Cipla Limited
Neutral

Frequently Asked Questions

What is Torrent Pharmaceuticals Limited share price today?▾
Torrent Pharmaceuticals Limited (TORNTPHARM) is currently trading at ₹4,416 on NSE, as of the last market session. Prices update daily after market close on MarketNetra.
Is Torrent Pharmaceuticals Limited available in F&O (Futures & Options)?▾
Yes, Torrent Pharmaceuticals Limited (TORNTPHARM) is part of the NSE F&O segment with a lot size of 250 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Torrent Pharmaceuticals Limited 52-week high and low?▾
Torrent Pharmaceuticals Limited's 52-week high is ₹4,714 and the 52-week low is ₹3,109. The current price of ₹4,416 is 6.3% below the 52W high.
What is Torrent Pharmaceuticals Limited P/E ratio?▾
Torrent Pharmaceuticals Limited's current P/E ratio is 66.4. This indicates the market is paying ₹66.4 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Torrent Pharmaceuticals Limited options?▾
Torrent Pharmaceuticals Limited options are traded on NSE with monthly expiry contracts (lot size: 250 shares). To trade TORNTPHARM options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.